Navigation Links
Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
Date:10/29/2010

Total current liabilities 1,171.2 1,020.0 Non-current liabilities: Convertible bonds 1,100.0 1,100.0 Other long-term debt 6.8 43.6 Deferred tax liability 356.1 294.3 Other non-current liabilities 169.7 247.1 Total liabilities 2,803.8 2,705.0 Equity: Common stock of 5p par value; 1,000 million shares authorized; and 562.2 million shares issued and outstanding (2009: 1,000 million shares authorized; and 561.5 million shares issued and outstanding) 55.7 55.6 Additional paid-in capital 2,731.9 2,677.6 Treasury stock: 14.9 million shares (2009: 17.8 million) (299.0) (347.4) Accumulated other comprehensive income 108.6 149.1 Accumulated deficit (299.4) (622.4) Total equity 2,297.8 1,912.5 Total liabilities and equity 5,101.6 4,617.5

Unaudited US GAAP results for the three months and nine months to September 30, 2010 Consolidated Statements of Income

9 months 9 months 3 months to 3 months to to to September September September 30, September 30, 30, 30, 2010 2009 2010 2009 $M $M $M $M Revenues: Product sales 794.3 602.5 2,276.8 1,916.8 Royalties 76.5 60.3 254.5 177.8 Other revenues 3.5 4.2 8.6 19.8 Total revenues 874.3 667.0 2,539.9 2,114.4 Costs and expenses: Cost of product sales(1) 112.7 104.9 333.7 284.9 Research and development 197.9 147.8 475.9 492.5 Selling, general and administrative(1) 392.4 320.6 1,106.7 973.8 Gain on sale of product rights - (6.3) (4.1) (6.3) Reorganization costs 9.7 2.0 23.3 7.1 Integration and acquisition costs 5.8 6.2 6.4 10.0 Total operating expenses 718.5 575.2 1,941.9 1,762.0 Operating income 155.8 91.8 598.0 352.4 Interest income 1.0 0.2 1.9 1.5 Interest expense (8.3) (9.4) (25.6) (30.6) Other income, net 0.8 7.0 9.0 61.9 Total other (expense)/income, net (6.5) (2.2) (14.7) 32.8 Income from continuing operations before income taxes and equity in (losses)/earnings of equity method investees 149.3 89.6 583.3 385.2 Income taxes (52.7) (30.6) (160.8) (56.7) Equity in (losses)/earnings of equity method investees, net of taxe
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
2. Reportlinker Adds Shire plc: PharmaVitae Profile
3. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
4. Shire plc - Statement re ProAmatine
5. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
6. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
7. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
8. Shire plc Appoints Two New Board Directors
9. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
10. Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)
11. INTUNIV(TM) - Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 Not long ... E&L studies should be performed late in the development ... known. But current regulatory trends suggest that, like many ... the rise. In recent years, multiple drug sponsors have ... or address specific questions during phase I/II. It’s not ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/20/2014)... improve the health of your heart, researchers have discovered. ... a standard TENS machine like those designed to relieve ... the small raised flap at the front of the ... The stimulation changed the influence of the nervous system ... can drive failing hearts too hard. , Professor Jim ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
Breaking Biology Technology:Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2'Tickling' your ear could be good for your heart 2EQ-5D™ Assessment Now Available for iPad 2
... Oct. 28 BioStorage Technologies, a global leader ... storage for the pharmaceutical and biotechnology industries, announces ... of global sales.   Atwood will ... and leadership of global sales initiatives. His key ...
... Calif., Oct. 28 ChromaDex Corporation (OTC Bulletin Board: ... of phytochemical and botanical reference standards and the creation ... appointed William F. Spengler to President of the Company, ... and diversified background to the position, having held leadership ...
... (Nasdaq: UTHR ) today announced its results of operations ... for the third quarter of 2010 were $171.0 million, up from ... the third quarter of 2010 was $39.7 million, or $0.70 per ... per basic share, for the same quarter in 2009. Gross margin ...
Cached Biology Technology:BioStorage Technologies Appoints New Vice President of Global Sales 2ChromaDex Names Pharmaceutical Industry Veteran William F. Spengler as President 2ChromaDex Names Pharmaceutical Industry Veteran William F. Spengler as President 3United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 2United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 3United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 4United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 5United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 6United Therapeutics Corporation Reports Third Quarter 2010 Financial Results 7
(Date:8/19/2014)... New Rochelle, August 19, 2014A new ovoid structure discovered ... iron-rich clay, contains a variety of minerals, and shows ... with resulting melting of the permafrost and mixing of ... a broad range of analytical studies to determine the ... hypotheses for how this ovoid formed, point to the ...
(Date:8/19/2014)... pain, but its effect on pain following brachial ... study reported on the Neural Regeneration Research ... of an avulsion injury to the left brachial ... were given electroacupuncture stimulation at bilateral Quchi (LI11), ... electroacupuncture therapy, chronic neuropathic pain in the rats, ...
(Date:8/19/2014)... 2014 Smart Technology Sector improves ... as latest developments, ad campaigns and partnerships are announced: ... EBAY ), Amazon.com Inc. (NASDAQ: AMZN ), ... (NASDAQ: GOOG ) and Mastercard Incorporated (NYSE: ... authentication company focused on the growing m-commerce market releases ...
Breaking Biology News(10 mins):Life on Mars? Implications of a newly discovered mineral-rich structure 2Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 2Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 3Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 4Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 5Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 6Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 7
... bathrooms may become a thing of the past with new ... at the University of New South Wales are developing new ... hospitals and the home. , Led by Professor ... for Functional Nanomaterials, a research team is studying tiny particles ...
... have made nisin, a natural antibiotic used for more than ... the first time using nature's toolbox. They also identified the ... its unique biological power. , The work -- published in ... the almost magical manner in which nisin is made in ...
... of malaria up to five months in advance has been developed ... uses predictions of climate variability to indicate the level of risk ... peak malaria season ?the earliest point at which predictions have ever ... providers in preventing and controlling the disease. , Malaria ...
Cached Biology News:Creation of antibiotic in test tube holds promise for better antibiotics 2Scientists develop malaria forecasting tool to predict disease risk 2
... tissue panels are designed for studying ... or proteins of interest in different ... positively charged glass slides. Total RNA ... identical format, and cDNA from those ...
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... The T2-02 diaphragm pump features T ... and achieves remarkable performance and efficiency. With ... performance range, T2-02 is ideal for use ... Offers ultra-compact size, long life, and high ...
Biology Products: